These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35196976)

  • 1. Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy.
    Ahmed LA; Al-Massri KF
    Curr Mol Pharmacol; 2023; 16(1):43-59. PubMed ID: 35196976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.
    Lee SH; Lee JH; Lee SW
    J Microbiol; 2024 Mar; 62(3):201-216. PubMed ID: 38635003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Cammarota G; Ianiro G; Bibbò S; Gasbarrini A
    Intern Emerg Med; 2014 Jun; 9(4):365-73. PubMed ID: 24664520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota medicine: towards clinical revolution.
    Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
    J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of Gut Microbiota on Metabolic Syndrome: A Patent Review.
    Singhal S; Rani V
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):17-26. PubMed ID: 35307002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Gut Microbiota in Complex Human Diseases.
    Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutual interplay of gut microbiota, diet and human disease.
    Illiano P; Brambilla R; Parolini C
    FEBS J; 2020 Mar; 287(5):833-855. PubMed ID: 31955527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic and Modulation of Microbiota: A New Paradigm?
    Rizzatti G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gut microbiota/microbiome in health and diseases: a review.
    Gomaa EZ
    Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol: striking the cardiovascular system by harming the gut microbiota.
    Silva CBP; Elias-Oliveira J; McCarthy CG; Wenceslau CF; Carlos D; Tostes RC
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H275-H291. PubMed ID: 34142885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative Review.
    Matzaras R; Nikopoulou A; Protonotariou E; Christaki E
    Yale J Biol Med; 2022 Dec; 95(4):479-494. PubMed ID: 36568836
    [No Abstract]   [Full Text] [Related]  

  • 18. Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.
    Olteanu G; Ciucă-Pană MA; Busnatu ȘS; Lupuliasa D; Neacșu SM; Mititelu M; Musuc AM; Ioniță-Mîndrican CB; Boroghină SC
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.
    Holmes A; Finger C; Morales-Scheihing D; Lee J; McCullough LD
    Transl Res; 2020 Dec; 226():39-56. PubMed ID: 32755639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebuilding the Gut Microbiota Ecosystem.
    Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.